Skip to main content
Top
Published in: Child's Nervous System 7/2017

01-07-2017 | Brief Communication

Tumor treating fields in pediatric high-grade glioma

Authors: Adam L. Green, Jean M. Mulcahy Levy, Rajeev Vibhakar, Molly Hemenway, Jennifer Madden, Nicholas Foreman, Kathleen Dorris

Published in: Child's Nervous System | Issue 7/2017

Login to get access

Abstract

Purpose

Tumor treating fields (TTF) are alternating electric fields applied continuously to the scalp. The treatment is approved for both primary and recurrent supratentorial adult glioblastoma but unstudied in children.

Methods

We report a feasibility case series of five pediatric high-grade glioma patients (ages 10–20 years) treated at our institution with TTF along with chemotherapy and/or radiation.

Results

Two patients began therapy at second recurrence and showed progressive disease. Two others were treated upfront after radiation therapy, and both showed partial responses. A fifth patient was treated at first recurrence and also showed a partial response. All five tolerated TTF well without treatment-limiting toxicities.

Conclusions

The tolerability of TTF, combined with the adult data, justify a pediatric clinical trial.
Literature
3.
go back to reference Wong ET, Toms SA, Ahluwalia MS (2015) Technological advances in the treatment of cancer: combining modalities to optimize outcomes. Clinical advances in hematology & oncology : H&O 13(11 Suppl 11):1–18 Wong ET, Toms SA, Ahluwalia MS (2015) Technological advances in the treatment of cancer: combining modalities to optimize outcomes. Clinical advances in hematology & oncology : H&O 13(11 Suppl 11):1–18
4.
go back to reference Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA et al (2015) Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA 314(23):2535–2543. doi:10.1001/jama.2015.16669 CrossRefPubMed Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA et al (2015) Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA 314(23):2535–2543. doi:10.​1001/​jama.​2015.​16669 CrossRefPubMed
5.
go back to reference Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V et al (2012) NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 48(14):2192–2202. doi:10.1016/j.ejca.2012.04.011 CrossRefPubMed Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V et al (2012) NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 48(14):2192–2202. doi:10.​1016/​j.​ejca.​2012.​04.​011 CrossRefPubMed
6.
Metadata
Title
Tumor treating fields in pediatric high-grade glioma
Authors
Adam L. Green
Jean M. Mulcahy Levy
Rajeev Vibhakar
Molly Hemenway
Jennifer Madden
Nicholas Foreman
Kathleen Dorris
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 7/2017
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-017-3431-0

Other articles of this Issue 7/2017

Child's Nervous System 7/2017 Go to the issue